Clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Haisco Pharmaceutical Group Co., Ltd.

• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
  NCT07583849 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study for HSK47388 in Participants With Ulcerative Colitis
  NCT07335055 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
  NCT07140328 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
  NCT07790510 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07007910 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
  NCT07363460 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Haisco Pharmaceutical Group Co., Ltd. recruiting for?

Haisco Pharmaceutical Group Co., Ltd. is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.